Exact Mass: 417.189
Exact Mass Matches: 417.189
Found 500 metabolites which its exact mass value is equals to given mass value 417.189
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(E)-Casimiroedine
(E)-Casimiroedine is found in pomes. (E)-Casimiroedine is an alkaloid from the seeds of Casimiroa edulis (Mexican apple
6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one
Hexanoic acid, 2-hydroxy-2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide
(4R)-7t-hydroxy-9c-hydroxymethyl-11-methoxy-5,12-dimethyl-(3ac,4at,13bt,13ct)-1,2,3a,4,4a,6,7,9,13b,13c-decahydro-5H-4r,6c-methano-benzo[h]oxazolo[3,2-a]pyrazino[3,2,1-de][1,5]naphthyridine-10,13-dione|Naphthyridinomycin|naphtyridinomycin-A
(-)-8beta-(4-hydroxybenzyl)-2,3-dimethoxyberbin-10-ol
(-)-1-[(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy]methyl-2-ethoxy-2-methylpropyl acetate
Ala Asn Val Asp
Ala Val Asn Asp
C22H27NO7_3,5,7,9-Undecatetraenoic acid, 2-ethylidene-11-[4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hex-1-yl]-4,10-dimethyl-11-oxo-, methyl ester, (2Z,3E,5E,7E,9E)
Ala Ala Ala Trp
Ala Ala Glu Gln
Ala Ala Gln Glu
Ala Ala Trp Ala
Ala Cys Lys Pro
Ala Cys Pro Lys
Ala Cys Pro Gln
Ala Cys Gln Pro
Ala Asp Gly Arg
Ala Asp Asn Val
Ala Asp Arg Gly
Ala Asp Val Asn
Ala Glu Ala Gln
Ala Glu Gln Ala
Ala Gly Asp Arg
Ala Gly Arg Asp
Ala Lys Cys Pro
Ala Lys Pro Cys
Ala Asn Asp Val
Ala Pro Cys Lys
Ala Pro Cys Gln
Ala Pro Lys Cys
Ala Pro Gln Cys
Ala Gln Ala Glu
Ala Gln Cys Pro
Ala Gln Glu Ala
Ala Gln Pro Cys
Ala Arg Asp Gly
Ala Arg Gly Asp
Ala Val Asp Asn
Ala Trp Ala Ala
Cys Ala Lys Pro
Cys Ala Pro Lys
Cys Ala Pro Gln
Cys Ala Gln Pro
Cys Lys Ala Pro
Cys Lys Pro Ala
Cys Pro Ala Lys
Cys Pro Ala Gln
Cys Pro Lys Ala
Cys Pro Gln Ala
Cys Gln Ala Pro
Cys Gln Pro Ala
Asp Ala Gly Arg
Asp Ala Asn Val
Asp Ala Arg Gly
Asp Ala Val Asn
Asp Gly Ala Arg
Asp Gly Ile Asn
Asp Gly Leu Asn
Asp Gly Asn Ile
Asp Gly Asn Leu
Asp Gly Gln Val
Asp Gly Arg Ala
Asp Gly Val Gln
Asp Ile Gly Asn
Asp Ile Asn Gly
Asp Leu Gly Asn
Asp Leu Asn Gly
Asp Asn Ala Val
Asp Asn Gly Ile
Asp Asn Gly Leu
Asp Asn Ile Gly
Asp Asn Leu Gly
Asp Asn Val Ala
Asp Gln Gly Val
Asp Gln Val Gly
Asp Arg Ala Gly
Asp Arg Gly Ala
Asp Val Ala Asn
Asp Val Gly Gln
Asp Val Asn Ala
Asp Val Gln Gly
Glu Ala Ala Gln
Glu Ala Gln Ala
Glu Gly Gly Arg
Glu Gly Asn Val
Glu Gly Arg Gly
Glu Gly Val Asn
Glu Asn Gly Val
Glu Asn Val Gly
Glu Gln Ala Ala
Glu Arg Gly Gly
Glu Val Gly Asn
Glu Val Asn Gly
Gly Ala Asp Arg
Gly Ala Arg Asp
Gly Asp Ala Arg
Gly Asp Ile Asn
Gly Asp Leu Asn
Gly Asp Asn Ile
Gly Asp Asn Leu
Gly Asp Gln Val
Gly Asp Arg Ala
Gly Asp Val Gln
Gly Glu Gly Arg
Gly Glu Asn Val
Gly Glu Arg Gly
Gly Glu Val Asn
Gly Gly Glu Arg
Gly Gly Arg Glu
Gly Gly Val Trp
Gly Gly Trp Val
Gly Ile Asp Asn
Gly Ile Asn Asp
Gly Leu Asp Asn
Gly Leu Asn Asp
Gly Met Asn Pro
Gly Met Pro Asn
Gly Asn Asp Ile
Gly Asn Asp Leu
Gly Asn Glu Val
Gly Asn Ile Asp
Gly Asn Leu Asp
Gly Asn Met Pro
Gly Asn Pro Met
Gly Asn Val Glu
Gly Pro Met Asn
Gly Pro Asn Met
Gly Gln Asp Val
Gly Gln Val Asp
Gly Arg Ala Asp
Gly Arg Asp Ala
Gly Arg Glu Gly
Gly Arg Gly Glu
Gly Val Asp Gln
Gly Val Glu Asn
Gly Val Gly Trp
Gly Val Asn Glu
Gly Val Gln Asp
Gly Val Trp Gly
Gly Trp Gly Val
Gly Trp Val Gly
Ile Asp Gly Asn
Ile Asp Asn Gly
Ile Gly Asp Asn
Ile Gly Asn Asp
Ile Asn Asp Gly
Ile Asn Gly Asp
Lys Ala Cys Pro
Lys Ala Pro Cys
Lys Cys Ala Pro
Lys Cys Pro Ala
Lys Pro Ala Cys
Lys Pro Cys Ala
Leu Asp Gly Asn
Leu Asp Asn Gly
Leu Gly Asp Asn
Leu Gly Asn Asp
Leu Asn Asp Gly
Leu Asn Gly Asp
Met Gly Asn Pro
Met Gly Pro Asn
Met Asn Gly Pro
Met Asn Pro Gly
Met Pro Gly Asn
Met Pro Asn Gly
Asn Ala Asp Val
Asn Ala Val Asp
Asn Asp Ala Val
Asn Asp Gly Ile
Asn Asp Gly Leu
Asn Asp Ile Gly
Asn Asp Leu Gly
Asn Asp Val Ala
Asn Glu Gly Val
Asn Glu Val Gly
Asn Gly Asp Ile
Asn Gly Asp Leu
Asn Gly Glu Val
Asn Gly Ile Asp
Asn Gly Leu Asp
Asn Gly Met Pro
Asn Gly Pro Met
Asn Gly Val Glu
Asn Ile Asp Gly
Asn Ile Gly Asp
Asn Leu Asp Gly
Asn Leu Gly Asp
Asn Met Gly Pro
Asn Met Pro Gly
Asn Pro Gly Met
Asn Pro Met Gly
Asn Pro Ser Thr
Asn Pro Thr Ser
Asn Ser Pro Thr
Asn Ser Thr Pro
Asn Thr Pro Ser
Asn Thr Ser Pro
Asn Val Ala Asp
Asn Val Asp Ala
Asn Val Glu Gly
Asn Val Gly Glu
Pro Ala Cys Lys
Pro Ala Cys Gln
Pro Ala Lys Cys
Pro Ala Gln Cys
Pro Cys Ala Lys
Pro Cys Ala Gln
Pro Cys Lys Ala
Pro Cys Gln Ala
Pro Gly Met Asn
Pro Gly Asn Met
Pro Lys Ala Cys
Pro Lys Cys Ala
Pro Met Gly Asn
Pro Met Asn Gly
Pro Asn Gly Met
Pro Asn Met Gly
Pro Asn Ser Thr
Pro Asn Thr Ser
Pro Gln Ala Cys
Pro Gln Cys Ala
Pro Gln Ser Ser
Pro Ser Asn Thr
Pro Ser Gln Ser
Pro Ser Ser Gln
Pro Ser Thr Asn
Pro Thr Asn Ser
Pro Thr Ser Asn
Gln Ala Ala Glu
Gln Ala Cys Pro
Gln Ala Glu Ala
Gln Ala Pro Cys
Gln Cys Ala Pro
Gln Cys Pro Ala
Gln Asp Gly Val
Gln Asp Val Gly
Gln Glu Ala Ala
Gln Gly Asp Val
Gln Gly Val Asp
Gln Pro Ala Cys
Gln Pro Cys Ala
Gln Pro Ser Ser
Gln Ser Pro Ser
Gln Ser Ser Pro
Gln Val Asp Gly
Gln Val Gly Asp
Arg Ala Asp Gly
Arg Ala Gly Asp
Arg Asp Ala Gly
Arg Asp Gly Ala
Arg Glu Gly Gly
Arg Gly Ala Asp
Arg Gly Asp Ala
Arg Gly Glu Gly
Arg Gly Gly Glu
Ser Asn Pro Thr
Ser Asn Thr Pro
Ser Pro Asn Thr
Ser Pro Gln Ser
Ser Pro Ser Gln
Ser Pro Thr Asn
Ser Gln Pro Ser
Ser Gln Ser Pro
Ser Ser Pro Gln
Ser Ser Gln Pro
Ser Thr Asn Pro
Ser Thr Pro Asn
Thr Asn Pro Ser
Thr Asn Ser Pro
Thr Pro Asn Ser
Thr Pro Ser Asn
Thr Ser Asn Pro
Thr Ser Pro Asn
Val Ala Asp Asn
Val Ala Asn Asp
Val Asp Ala Asn
Val Asp Gly Gln
Val Asp Asn Ala
Val Asp Gln Gly
Val Glu Gly Asn
Val Glu Asn Gly
Val Gly Asp Gln
Val Gly Glu Asn
Val Gly Gly Trp
Val Gly Asn Glu
Val Gly Gln Asp
Val Gly Trp Gly
Val Asn Ala Asp
Val Asn Asp Ala
Val Asn Glu Gly
Val Asn Gly Glu
Val Gln Asp Gly
Val Gln Gly Asp
Val Trp Gly Gly
Trp Ala Ala Ala
Trp Gly Gly Val
Trp Gly Val Gly
Trp Val Gly Gly
1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium methyl sulphate
N,N-DIMETHYL-4-((4-((4-((TRIMETHYLSILYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)ANILINE
ZSTK474
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
4-Nitrophenyl phosphate bis(cyclohexylammonium) salt
Benzenebutanamide,4-fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride
cyclohexanamine,(3-nitrophenyl) dihydrogen phosphate
Benzenepropanoic acid, 4,4-(phenylimino)bis-,1,1-dimethyl ester
6-Chloro-1-methyl-2,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
(5-acetamido-3,4-diacetyloxy-6-pentoxyoxan-2-yl)methyl acetate
TEGASEROD MALEATE
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod maleate has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod maleate causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod maleate has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].
5-(4-Methyl-benzoylamino)-biphenyl-3,4-dicarboxylic acid 3-dimethylamide-4-hydroxyamide
Closiramine aceturate
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Naphthalen-1-yl-(5-naphthalen-1-yl-1-pentylpyrrol-3-yl)methanone
(2E,6R)-6-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}hept-2-enoic acid
N-[6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-3-yl]hex-4-ynyl]methanesulfonamide
N-[4-[3-[4-(5-chloro-2-methylphenyl)-1-piperazinyl]-2-hydroxypropoxy]phenyl]acetamide
(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine
(2R)-({4-[Amino(imino)methyl]phenyl}amino){5-ethoxy-2-fluoro-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl}aceticacid
N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide
(3Z)-3-[(2E,4E,6R)-1-hydroxy-4-methyl-6-[(2S,7R,8R)-1,2,7-trimethyl-5-oxo-3,9,10-trioxatricyclo[4.3.1.02,4]decan-8-yl]hepta-2,4-dienylidene]pyrrolidine-2,4-dione
(2E,3E,5E,7E,9E)-2-ethylidene-11-[(1R,4S,5R)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoic acid
beta-Aminoarteether maleate
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
N-[4-[[2-methoxy-5-(4-oxo-2,3-dihydro-1H-quinazolin-2-yl)phenyl]methoxy]phenyl]acetamide
2-amino-7-methyl-5-oxo-6-(2-phenylethyl)-4-(3-pyridinyl)-4H-pyrano[3,2-c]pyridine-3-carboxylic acid methyl ester
methyl (2Z,3E,5E,7E,9E)-2-ethylidene-11-[4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
3-[6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-6-oxohexyl]-2-sulfanylidene-1H-quinazolin-4-one
2-(1-Benzimidazolyl)acetic acid [2-[1-(4-methoxyphenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester
3-Furanyl-[4-[2-(3-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
2-Furanyl-[4-[2-(4-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
3-Furanyl-[4-[2-(4-methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
2-ethyl-4-[[(3-methyl-2-benzofuranyl)-oxomethyl]amino]-1H-1,5-benzodiazepine-3-carboxylic acid ethyl ester
2-amino-6-(3-imidazol-1-ylpropyl)-4-(2-methoxyphenyl)-7-methyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile
1-(3-Chlorophenyl)-3-[[1-[(2,5-dimethoxyphenyl)methyl]-4-piperidinyl]methyl]urea
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
Methyl (2E,3E,5E,7E,9E)-2-ethylidene-11-[(1R,5R)-4-hydroxy-4-(2-hydroxyethyl)-2-oxo-6-oxa-3-azabicyclo[3.1.0]hexan-1-yl]-4,10-dimethyl-11-oxoundeca-3,5,7,9-tetraenoate
Asp-Gln-Arg
A tripeptide composed of L-aspartic acid, L-glutamine and L-arginine joined in sequence by peptide linkages.
1-(4-(5-(Furan-2-yl)-2-(3-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanone
3-[1-[Oxo-(1-phenylcyclopentyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylmethanesulfonamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
1-[(2S,3S,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(3aS,4S,9bS)-8-(2-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone
(1S,5R)-N-(2-fluorophenyl)-7-[4-(3-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide
(3-fluorophenyl)-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]propanamide
1-[(2R,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2R,3R,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2S,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(2R,3R,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea
1-[(3aS,4S,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aR,4R,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aR,4R,9bR)-8-(2-fluorophenyl)-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone
(1R,5S)-N-(2-fluorophenyl)-7-[4-(3-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
(1S,5R)-N-(4-fluorophenyl)-7-[4-(4-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-4-[1-oxo-2-(3-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(3-fluorophenyl)-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
(3-fluorophenyl)-[(2R,3S)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
(3-fluorophenyl)-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-1-(2-pyridinylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-4-[oxo(2-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioic acid
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}-2,2-diphenylacetamide
4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine
2-N-[(1R)-1-[4-(4-methoxyphenoxy)phenyl]ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine
2-(2-methylindol-1-yl)-1-[(2S)-2-(piperidine-1-carbonyl)-2,3-dihydro-1,4-benzoxazin-4-yl]ethanone
RS504393
casimiroedine
Ansofaxine hydrochloride
Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor; inhibits serotonin, dopamine and norepinephrine reuptake with IC50 values of 723, 491 and 763 nM, respectively.